News
FDA issues new policy for evaluating impact of viral mutations on COVID-19 tests
24 February 2021
CounselPhiladelphia
Email blake.wilson@hoganlovells.com
Phone +1 267 675 4633
Fax +1 267 675 4601
Practice groupGlobal Regulatory
When clients need help with premarket clearance and approval of new medical devices, Blake Wilson leverages his background in the life sciences industry to smooth regulatory hurdles.
Blake has advised on 510(k) premarket notifications, de novo submissions, premarket approval applications (PMAs), and investigational device exemption applications, among other regulatory filings. He also has experience in drafting clinical trial agreements and contracts for device development, manufacturing, and associated Quality System Regulation (QSR) responsibilities.
Prior to joining Hogan Lovells, Blake worked as an associate at another international law firm and was a lead research assistant at Brown University, where he managed phase 1 and 2 pharmaceutical clinical trials. Blake takes advantage of his clinical research background to help companies navigate the FDA's clinical data requirements.
While attending law school, Blake was executive editor for the University of Pennsylvania Journal of International Law and published a student comment regarding the use and regulation of foreign clinical trials in the FDA's drug marketing approval process. He also served as a judicial intern to the Honorable Leonard P. Stark of the U.S. District Court for the District of Delaware.
Healthcare: Life Sciences, Rising Star
Legal 500 US
Education
M.S. Biostatistics, Columbia University, Mailman School of Public Health, 2021
J.D., University of Pennsylvania Law School, 2012
Certificate in Business Economics and Public Policy, University of Pennsylvania, Wharton School of Business, 2012
B.S., Northeastern University, summa cum laude, 2007
Memberships
Pennsylvania Bar Association, 2011 - Present
Bar admissions and qualifications
Pennsylvania
New Jersey
News
24 February 2021
Hogan Lovells Publications
23 February 2021
Press Releases
05 January 2021
Sponsorships and Speaking Engagements
19-20 November 2020
News
12 November 2020
Published Works
04 November 2020